• Explore /
  • Poster
  • / A pilot study of gut microbiome modulation to enable efficacy of neoadjuvant checkpoint-based immunotherapy (IO) following chemotherapy in pancreatic ductal adenocarcinoma (PDAC).

A pilot study of gut microbiome modulation to enable efficacy of neoadjuvant checkpoint-based immunotherapy (IO) following chemotherapy in pancreatic ductal adenocarcinoma (PDAC).

Abstract Poster

Authors

null

Linda Wu

Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY;

Linda Wu , Celina Ang , Sofya Pintova , Max W. Sung , Peter Kozuch , Sirish Dharmapuri , Noah A Cohen , Myron E. Schwartz , John P. Mandeli , Deepak Saxena , Deirdre Jill Cohen

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT05462496

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr TPS759)

DOI

10.1200/JCO.2023.41.4_suppl.TPS759

Abstract #

TPS759

Poster Bd #

P15

Abstract Disclosures

Similar Posters

First Author: Benjamin Adam Weinberg

First Author: Anser Ali Abbas

First Author: Benjamin Adam Weinberg

First Author: Luis I. Ruffolo